Ming-hao Li
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial.
Journal: Blood cancer journal
Published: July 18, 2025
Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy.
Journal: Frontiers in immunology
Published: April 17, 2022
Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells.
Journal: Biochemical and biophysical research communications
Published: January 18, 2022
CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic Metabolism.
Journal: Frontiers in cell and developmental biology
Published: December 14, 2020
Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia.
Journal: Leukemia
Published: August 09, 2018
Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 07, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026